Here, pre-interventional serum concentrations of IL-8 and IL-6 were significantly elevated in patients with liver cancer compared to healthy controls (Figure 1A,B, Table 1), while serum levels of CCL22 were unaltered between these groups (Figure 1C). The gene discussed is IL6; the disease is liver cancer.